Publication Name	World Journal of Virology
Manuscript ID	63465
Country	Thailand

Received	2021-01-28 14:59
Peer-Review Started	2021-01-28 15:05
To Make the First Decision
Return for Revision	2021-02-25 01:25
Revised	2021-03-10 14:27
Second Decision	2021-04-26 08:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-26 11:37
Articles in Press	2021-04-26 11:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-14 19:47
Typeset the Manuscript	2021-05-18 01:47
Publish the Manuscript Online	2021-05-18 11:27

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Minireviews
Article Title	Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in COVID-19 patients
Manuscript Source	Invited Manuscript
All Author List	Wattana Leowattana
ORCID	Author(s) ORCID Number Wattana Leowattana http://orcid.org/0000-0003-4257-2480
Funding Agency and Grant Number
Corresponding Author	Wattana Leowattana, BSc, MD, MSc, PhD, Associate Professor, Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, 420/6 rajavithi road, rachatawee, Bangkok 10400, Thailand. wattana.leo@mahidol.ac.th
Key Words	SARS-CoV-2; COVID-19; Hepatobiliary tissue; Angiotensin converting enzyme 2; Chronic liver disease; Common medications; Clinical outcome
Core Tip	With more than 100 million confirmed cases worldwide, hepatobiliary injury has been reported in many coronavirus disease 2019 (COVID-19) patients. The association between COVID-19 and hepatobiliary injury refers to any hepatobiliary damage during disease progression and treatment in COVID-19 patients with or without chronic liver diseases or common medications. Angiotensin-converting enzyme 2 receptor may be a significant factor in hepatobiliary derangement due to its highly expressed cholangiocyte, and it is also an entry point of severe acute respiratory syndrome coronaviruses 2. Moreover, drug-induced liver injury and cytokine storm may be an added risk in severe clinical outcomes. Close monitoring of the liver function in COVID-19 patients is mandatory.
Publish Date	2021-05-18 11:27
Citation	Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in COVID-19 patients. World J Virol 2021; 10(3): 86-96
URL	https://www.wjgnet.com/2220-3249/full/v10/i3/86.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i3.86

Full Article (PDF)	WJV-10-86.pdf
Full Article (Word)	WJV-10-86.docx
Manuscript File	63465-Review-FilipodiaCL.docx
Answering Reviewers	63465-Answering reviewers.pdf
Audio Core Tip	63465-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	63465-Conflict-of-interest statement.pdf
Copyright License Agreement	63465-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	63465-Language certificate.pdf
Peer-review Report	63465-Peer-review(s).pdf
Scientific Misconduct Check	63465-Bing-Wang JL-1.jpg
Scientific Misconduct Check	63465-Scientific misconduct check.pdf
Scientific Editor Work List	63465-Scientific editor work list.pdf